News Releases
Risk Statement: Benzene is classified as a human carcinogen. Exposure to benzene can occur by inhalation, orally, and through the skin and it potentially can result in cancers including leukemia and blood cancer of the bone marrow and blood disorders which can be life threatening. Insight is recalling these products out of an abundance of caution. To date, the Company has not received any serious adverse events related to this recall. Benzene is ubiquitous in the environment. Humans around the world have daily exposures to it indoors and outdoors from multiple sources.
TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid is packaged in blue and white aerosol cans with Lot codes located on the bottom of the can.
Samples of the recalled lots below have been found to contain elevated levels of Benzene related to the propellant that sprays the product out of the can. Benzene is not an ingredient in any Ting products.
Product | NDC | Lot Code | Expiration | Package Size |
TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid | 63736-819-05 | 0H50545 | 07/24 | 4.5 oz/128 g |
TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid | 63736-819-05 | 1G50645 | 06/25 | 4.5 oz/128 g |
The affected TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid lots were distributed nationwide in
Insight has notified retailers via overnight mail to remove any remaining recalled product from shelves and follow the instructions provided in the Drug Recall Notification. The company will also offer reimbursement for consumers who have purchased TING® 1% Tolnaftate Athlete’s Foot Spray Antifungal Spray Liquid marked with one of the lot codes in the table above. Consumers can contact
No serious adverse events have been reported to date.
Consumers with questions regarding this recall can contact
Adverse reactions or quality problems experienced with the use of this product may be reported to the
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/4e67b6ae-69a2-4b42-aee6-cff9f651a24a
Investor Relations ContactPhil Terpolilli , CFA, 914-524-6819 irinquiries@prestigebrands.com
Source: Prestige Consumer Healthcare Inc.